Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$552M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$519M |
| 3 |
Microsoft
MSFT
|
+$417M |
| 4 |
Apple
AAPL
|
+$376M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.4B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$396M |
| 3 |
Estee Lauder
EL
|
+$326M |
| 4 |
TSG
The Stars Group Inc.
TSG
|
+$302M |
| 5 |
S&P Global
SPGI
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.93% |
| 2 | Financials | 5.77% |
| 3 | Consumer Discretionary | 5.25% |
| 4 | Healthcare | 5.08% |
| 5 | Communication Services | 4.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VISN
3376
Vistance Networks Inc
VISN
$2.82B
| $1.14M | ﹤0.01% |
137,223
+105,812
| +337% | +$1.04M |
|
3377
Protagonist Therapeutics
PTGX
$8.73B
| $1.14M | ﹤0.01% |
64,547
+57,525
| +819% | +$722K |
|
|
BPY
3378
CALL
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $1.14M | ﹤0.01% |
115,300
+44,100
| +62% | +$433K |
|
3379
Amkor Technology
AMKR
$13.9B
| $1.14M | ﹤0.01% |
92,374
-107,983
| -54% | -$1.11M |
|
3380
CALL
iShares MSCI United Kingdom ETF
EWU
$4.14B
| $1.14M | ﹤0.01% |
44,100
-75,800
| -63% | -$1.92M |
|
3381
CALL
Huntsman Corp
HUN
$1.83B
| $1.14M | ﹤0.01% |
63,200
-21,100
| -25% | -$354K |
|
3382
Quaker Houghton
KWR
$2.98B
| $1.14M | ﹤0.01% |
6,119
+160
| +3% | +$25.1K |
|
3383
Madrigal Pharmaceuticals
MDGL
$11.7B
| $1.14M | ﹤0.01% |
10,024
+683
| +7% | +$67.2K |
|
3384
Pricesmart
PSMT
$5.97B
| $1.14M | ﹤0.01% |
18,829
-1,394
| -7% | -$80.4K |
|
3385
Marriott Vacations Worldwide
VAC
$3.39B
| $1.14M | ﹤0.01% |
13,815
-1,732
| -11% | -$141K |
|
3386
PUT
Knight Transportation
KNX
$11.7B
| $1.14M | ﹤0.01% |
27,200
-6,000
| -18% | -$229K |
|
3387
United Parks & Resorts
PRKS
$2.18B
| $1.14M | ﹤0.01% |
76,637
+44,966
| +142% | +$662K |
|
|
MRO
3388
CALL
DELISTED
Marathon Oil Corporation
MRO
| $1.13M | ﹤0.01% |
185,100
+44,600
| +32% | +$247K |
|
|
CS
3389
PUT
DELISTED
Credit Suisse Group
CS
| $1.13M | ﹤0.01% |
109,900
+28,600
| +35% | +$257K |
|
3390
Artisan Partners
APAM
$3.03B
| $1.13M | ﹤0.01% |
34,831
+2,997
| +9% | +$83.1K |
|
3391
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.31B
| $1.13M | ﹤0.01% |
24,168
+221
| +0.9% | +$9.82K |
|
3392
TechTarget
TTGT
$317M
| $1.13M | ﹤0.01% |
37,679
+22,363
| +146% | +$564K |
|
3393
Mesa Laboratories
MLAB
$566M
| $1.13M | ﹤0.01% |
5,209
+3,480
| +201% | +$802K |
|
3394
CALL
Groupon
GRPN
$1.04B
| $1.13M | ﹤0.01% |
62,290
-2,095
| -3% | -$46.6K |
|
3395
WaFd
WAFD
$2.79B
| $1.13M | ﹤0.01% |
42,053
-8,121
| -16% | -$209K |
|
3396
Bank of Hawaii
BOH
$3.19B
| $1.13M | ﹤0.01% |
18,371
+12,951
| +239% | +$800K |
|
|
CADE
3397
DELISTED
Cadence Bank
CADE
| $1.13M | ﹤0.01% |
49,615
-28,658
| -37% | -$608K |
|
3398
Columbia Banking Systems
COLB
$8.99B
| $1.13M | ﹤0.01% |
39,786
+18,397
| +86% | +$469K |
|
3399
Cue Biopharma
CUE
$112M
| $1.13M | ﹤0.01% |
1,534
+1,332
| +659% | +$965K |
|
3400
Ichor Holdings
ICHR
$2.48B
| $1.13M | ﹤0.01% |
42,437
+8,323
| +24% | +$190K |
|
Similar funds
Citigroup's Q2 2020 Portfolio in Review
As of Q2 2020, Citigroup held 7,909 positions worth $128B, up 16% from $111B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citigroup withdrew a net $7.44B in Q2 2020, closing 313 positions and reducing 3,200 holdings. Its most notable exit was Allergan plc, an estimated $1.4B position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 6.7% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Invesco Dorsey Wright Technology Momentum ETF worth $156M.
- Citigroup's largest Q2 2020 buy was Invesco Dorsey Wright Technology Momentum ETF: 4,800,363 shares worth $156M.
- Citigroup added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2020, an estimated $552M increase.
- Citigroup's biggest Q2 2020 reduction was Alphabet (Google) Class A, cutting an estimated $396M.
- Citigroup fully exited Allergan plc in Q2 2020, selling an estimated $1.4B.
- Citigroup's ten largest holdings make up 23% of its $128B portfolio in Q2 2020.
- Citigroup opened 257 new positions and closed 313 in Q2 2020.
- Citigroup's portfolio value rose 16% quarter-over-quarter to $128B.
Based on Citigroup's 13F filing for Q2 2020, filed 12 Aug 2020.